Skip to main content

Ginkgo Bioworks Holdings, Inc.

DNA
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001830214

In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $359.2M in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Ginkgo Bioworks Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
183
+11 vs. Q1 2026
Shares held
36.2M
+3.88M (+12.0%) vs. Q1 2026
Total value
$359.2M
+$162.4M (+82.5%) vs. Q1 2026
New holders
30
69 more added
Sold out
19
39 more reduced

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 183 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 125 institutionsQ4 2021: 164 institutionsQ1 2022: 191 institutionsQ2 2022: 263 institutionsQ3 2022: 279 institutionsQ4 2022: 323 institutionsQ1 2023: 316 institutionsQ2 2023: 316 institutionsQ3 2023: 350 institutionsQ4 2023: 343 institutionsQ1 2024: 340 institutionsQ2 2024: 315 institutionsQ3 2024: 159 institutionsQ4 2024: 166 institutionsQ1 2025: 167 institutionsQ2 2025: 166 institutionsQ3 2025: 174 institutionsQ4 2025: 181 institutionsQ1 2026: 175 institutionsQ2 2026: 183 institutions
Value heldQ2 2026: $359.2M
Q1 2021: $0Q2 2021: $0Q3 2021: $9.18BQ4 2021: $7.38BQ1 2022: $2.68BQ2 2022: $1.93BQ3 2022: $2.74BQ4 2022: $1.68BQ1 2023: $1.51BQ2 2023: $2.25BQ3 2023: $2.25BQ4 2023: $2.14BQ1 2024: $1.50BQ2 2024: $311.5MQ3 2024: $214.5MQ4 2024: $318.9MQ1 2025: $184.2MQ2 2025: $375.0MQ3 2025: $437.0MQ4 2025: $270.3MQ1 2026: $197.0MQ2 2026: $359.2M
Institutions holding DNA and their total value by quarter
QuarterHoldersValue
Q2 2026183$359.2M
Q1 2026175$197.0M
Q4 2025181$270.3M
Q3 2025174$437.0M
Q2 2025166$375.0M
Q1 2025167$184.2M
Q4 2024166$318.9M
Q3 2024159$214.5M
Q2 2024315$311.5M
Q1 2024340$1.50B
Q4 2023343$2.14B
Q3 2023350$2.25B
Q2 2023316$2.25B
Q1 2023316$1.51B
Q4 2022323$1.68B
Q3 2022279$2.74B
Q2 2022263$1.93B
Q1 2022191$2.68B
Q4 2021164$7.38B
Q3 2021125$9.18B
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Ginkgo Bioworks Holdings, Inc.; share changes are against Q1 2026.

Institutions holding DNA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Root Financial Partners, LLC0$00.00%−24−100.0%Sold out
Vanguard National Trust Co0$00.00%−10−100.0%Sold out
CWM, LLC––––Not filed
Janus Henderson Group PLC––––Not filed
Sunbelt Securities, Inc.––––Not filed